ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,321Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 559

$710K Total Retail Price of All Prescriptions

Rank: 14 out of 559

771 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 771 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 771 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 13,010 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 912 742 1 1
LEVOTHYROXINE SODIUM 804 576 2 2
SIMVASTATIN 763 628 3 3
OMEPRAZOLE 669 486 4 4
METFORMIN HCL 634 485 5 5
AMLODIPINE BESYLATE 520 420 6 6
LOSARTAN POTASSIUM 438 334 7 14
HYDROCHLOROTHIAZIDE 424 363 8 8
GABAPENTIN 348 228 9 9
HYDROCODONE-ACETAMINOPHEN 314 190 S3 10 7
ALENDRONATE SODIUM 308 271 11 13
METOPROLOL SUCCINATE 291 259 12 16
FUROSEMIDE 270 235 13 11
TAMSULOSIN HCL 270 233 13 25
MELOXICAM 265 230 15 42
PROAIR HFA 248 131 16 29
ZOLPIDEM TARTRATE 205 136 17 17
POTASSIUM CHLORIDE 205 167 17 23
CYCLOBENZAPRINE HCL 203 142 R 19 54
METOPROLOL TARTRATE 202 151 20 12
MIRTAZAPINE 202 152 20 61
WARFARIN SODIUM 196 160 22 24
TRAMADOL HCL 181 130 23 27
CEFUROXIME 173 129 24 128
FLUOXETINE HCL 167 107 25 37
GLYBURIDE 166 118 R 26 45
FLUTICASONE PROPIONATE 165 107 27 22
GEMFIBROZIL 151 103 28 71
CITALOPRAM HBR 150 128 29 21
SPIRIVA 150 131 29 67
FAMOTIDINE 149 108 31 93
ATENOLOL 146 111 32 15
ADVAIR DISKUS 146 103 32 46
SERTRALINE HCL 131 77 34 19
CLONIDINE HCL 130 104 35 68
PREDNISONE 124 100 36 49
CARVEDILOL 122 91 37 38
HYDRALAZINE HCL 116 91 38 143
DOXAZOSIN MESYLATE 111 80 39 43
CLOPIDOGREL 111 82 39 51
ATORVASTATIN CALCIUM 109 92 41 20
AMITRIPTYLINE HCL 107 84 R 42 58
POLYETHYLENE GLYCOL 3350 104 51 43 133
PRAVASTATIN SODIUM 103 64 44 35
BENAZEPRIL HCL 100 65 45 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 97 46 18
RANITIDINE HCL 94 58 47 26
TRAZODONE HCL 91 63 48 28
CIPROFLOXACIN HCL 84 70 49 60
PLAVIX 84 61 49 76
LABETALOL HCL 82 62 51 185
LANTUS 79 35 52 40
DILTIAZEM 24HR CD 78 63 53 152
KLOR-CON M10 77 68 54 140
DONEPEZIL HCL 75 75 55 36
FELODIPINE ER 75 63 55 72
NEXIUM 73 46 57 57
IBUPROFEN 71 43 58 30
PAROXETINE HCL 70 58 59 48
BETAMETHASONE DIPROPIONATE 69 58 60 224
BUSPIRONE HCL 69 44 60 172
CYMBALTA 68 33 62 78
SYMBICORT 66 59 63 175
DIOVAN 66 50 63 55
DIGOXIN 63 46 65 94
LYRICA 61 59 66 125
GLIPIZIDE 59 52 67 31
AZITHROMYCIN 55 31 68 39
BACLOFEN 54 23 69 90
AVODART 53 53 70 124
OXYBUTYNIN CHLORIDE 53 51 70 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 37 72 96
RISPERIDONE 50 37 73 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 19, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.